Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 6
Submit an article Journal homepage
1,367
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling

Juanjuan Caia Department of Pharmacy, The Affiliated Hospital of Medical School, Ningbo University, Ningbo city, Zhejiang, ChinaCorrespondence[email protected]
View further author information
,
Lingling Sua Department of Pharmacy, The Affiliated Hospital of Medical School, Ningbo University, Ningbo city, Zhejiang, ChinaView further author information
&
Weiwei Luob Department of Pharmacy, Ningbo No. 6 Hospital, Ningbo city, Zhejiang, ChinaView further author information
Pages 14450-14459 | Received 23 Mar 2022, Accepted 02 Jun 2022, Published online: 26 Jun 2022

References

  • De Rosa M, Pace U, Rega D, et al. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34(3):1087–1096.
  • Bogaert J, Prenen H. Molecular genetics of colorectal cancer. Ann Gastroenterol. 2014;27(1):9–14.
  • He R, Lao Y, Yu W, et al. Progress in the application of immune checkpoint inhibitor-based immunotherapy for targeting different types of colorectal cancer. Front Oncol. 2021;11:764618.
  • Carrato A. Adjuvant treatment of colorectal cancer. Gastrointest Cancer Res. 2008;2(4 Suppl):S42–S46.
  • Biller L, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669–685.
  • Shohayeb B, Mitchell N, Millard SS, et al. Elevated levels of drosophila Wdr62 promote glial cell growth and proliferation through AURKA signalling to AKT and MYC. Biochim Biophys Acta, Mol Cell Res. 2020;1867(7):118713.
  • Bu Y, Zhang L, Ma X, et al. Systematic analysis of the oncogenic role of WDR62 in human tumors. Dis Markers. 2021;2021:1–23.
  • Sugita S, Yoshino H, Yonemori M, et al. Tumor‑suppressive microRNA‑223 targets WDR62 directly in bladder cancer. Int J Oncol. 2019;54(6):2222–2236.
  • Zhang Y, Tian Y, Yu -J-J, et al. Overexpression of WDR62 is associated with centrosome amplification in human ovarian cancer. J Ovarian Res. 2013;6(1):55.
  • Shinmura K, Kato H, Kawanishi Y, et al. WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma. Mol Carcinog. 2017;56(8):1984–1991.
  • Zeng S, Tao Y, Huang J, et al. WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer. Eur J Cancer. 2013;49(17):3752–3762.
  • Yaqin Li LZ, Gong J. Naringin attenuated acute lung injury in rat model with acute pancreatitis in pregnancy through inactivation of p38 MAPK pathway. Signa Vitae. 2020;16(2):189–194.
  • Lee S, Rauch J, Kolch W. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21(3):1102.
  • Pranteda A, Piastra V, Stramucci L, et al. The p38 MAPK signaling activation in colorectal cancer upon therapeutic treatments. Int J Mol Sci. 2020;21(8):2773.
  • Zhang Y, Li C, Liu X, et al. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. EBioMedicine. 2019;48:277–288.
  • Popp HD, Brendel S, Hofmann W-K, et al. Immunofluorescence microscopy of γH2AX and 53BP1 for analyzing the formation and repair of DNA double-strand breaks. J Vis Exp. 2017;129:e56617.
  • Hsu -H-H, Chen M-C, Baskaran R, et al. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol. 2018;233(7):5458–5467.
  • Mehmood RK, Parker J, Ahmed S, et al. Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibodies perspective. World J Oncol. 2014;5(3):97–108.
  • Zhou Y, Wan G, Spizzo R, et al. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 2014;8(1):83–92.
  • Causse SZ, Marcion G, Chanteloup G, et al. HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells. Oncogene. 2019;38(15):2767–2777.
  • Wang Y-S, Chen C, Ahmad MJ, et al. WDR62 regulates mouse oocyte meiotic maturation related to p-JNK and H3K9 trimethylation. Int J Biochem Cell Biol. 2022;144:106169.
  • Liu H, Hu H-C, Chao J-I. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells. Chem Biol Interact. 2010;188:535–545.
  • Chocry M, Leloup L, Kovacic H. Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain/Nox1 pathway. Oncotarget. 2017;8(61):103710–103730.
  • Wasserman T, Katsenelson KC, Daniliuc S, et al. A novel c-Jun N-terminal Kinase (JNK)-binding protein WDR62 is recruited to stress granules and mediates a nonclassical JNK activation. Mol Biol Cell. 2010;21:117–130.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.